Relative risk reduction versus number needed to treat as measures of lipid-lowering trial results

American Journal of Cardiology

Volumn 82, Issue 4, 1998, Pages 505-507

  Moriarty, Patrick M ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b 4026 Wescoe ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY RISK; DYSLIPIDEMIA; EDITORIAL; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK MANAGEMENT; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031845986     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00367-1     Document Type: Article

References (11)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
2. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Deciding on best therapy. In: Clinical Epidemiology-A Basic Science for Clinical Medicine. 2nd ed. Boston/Toronto/London: Little, Brown, 1991:205.
3. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318:1728-1733.
4. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: III. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects. Circulation 1972;45:991-1004.
5. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4,444 patients with coronary artery disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1995;344:1383-1389.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
7. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of Coronary Heart Disease with Pravastatin in men with hypercholesterolemia. N Engt J Med 1995;333:1301-1306.
8. Sacks FM, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335: 1001-1009.
9. Cox DR. Regression methods of life tables (with discussion). J R Stat Soc 1972; B34:187-220.
10. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts: Prospective Studies Collaboration. Lancet 1995;346:1647-1653.
11. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997; 126:712-720.